Innovative Design and Implementation of Next-Generation Point-of-Care CAR-T
InnoCAR-T is a Doctoral Network designed to provide training and carry out breakthrough research on the high-impact field of Chimeric Antigen Receptor (CAR) T cell immunotherapy in a carefully integrated academic and inter-sectoral programme.
The network aims to develop next-generation CAR-T therapy and deliver a set of young researchers uniquely qualified for a career in academia and/or industry. At the core of InnoCAR-T lies its cutting-edge multidisciplinary training programme. Outstanding young scientists will be able to generate breakthrough ideas and assume leading positions in academia and industry. The training programme includes an array of disciplines, ranging from biomedical sciences (e.g., immunology, CAR engineering, gene-editing), physical sciences to mechanical engineering. Industrial partners are central to the programme and provide pivotal expertise on how to translate scientific discoveries into commercial reality. Inter-sectoral partners will host Doctoral Candidates, provide key secondments and networkwide training events. Furthermore, InnoCAR-T will foster long-term multi-disciplinary research and bilateral cooperation between academia and industry.
- Professor Edwin BremerAcademisch Ziekenhuis GroningenEmail
- Horizon Europe & sub-programmes
- 48 months (January 2023 - December 2026)
- Project funding
- € 2,618,856.00
- Project partners
- Project website
- https://www.innocar-t.eu Download Factsheet